Company Name:
Description:

Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized anti-cancer and palliative treatments.

The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research.

The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations and diagnostics. Cannabics engages in developing individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools.

Cannabics Pharmaceuticals is traded in the OTCQB US stock exchange, under the trade symbol CNBX

Social:
Contact Information